NIFTY  8,879.60  -0.19%
  SENSEX  28,743.30  -0.24%
 CURRENCY  Rs  66.71/$ 70.60/€, 82.92/£
  GOLD  29,582.00  -0.43%
  SILVER  43,291.00  -0.31%
  DAX  11,822.70  0.16%
  FTSE  7,253.00  0.13%
  CAC  4,845.18  -0.00%
  HANG SENG  23,740.70  -0.77%
  NIKKEI  19,119.00  0.06%
  Shanghai Composite  3,241.73  0.22%
  DOW JONES  20,837.40  0.07%
  NASDAQ  5,861.90  0.28%
  S&P 500  2,369.75  0.10%
DEA SECRETARY - GDP Completely Negates Note Ban Apprehensions DEA SECRETARY - Manufacturing Sector Growth Is Very Satisfying

Ranbaxy To Pay $500 Mn To Settle Adulterated Drugs Sale Charges

Video:

Play this video

In the largest settlement with a generic pharma major over drug safety, Ranbaxy has pleaded guilty to felony charges related to drug safety and will pay $500 million in civil and criminal fines. The company was said to sell adulterated drugs while lying about it to US regulators. Ranbaxy has admitted that it sold batches of drugs that were improperly manufactured, stored and tested.